2021
DOI: 10.1016/j.annonc.2021.08.1701
|View full text |Cite
|
Sign up to set email alerts
|

1729TiP Rationale and design of the phase IIb/III VOICE trial of clonidine MBT for the prevention of severe oral mucositis in patients with OPC receiving chemoradiotherapy

Abstract: and 15.0% of the patients presented 2 and 3 symptoms. The 4 most common symptoms were pain (16.2%), general weakness (12.3%), dyspnea (12.2%), and fever (11.3%). According to patients' situation, 59.2% of ED visits lead to hospitalization in inpatients units for a stay of 8.2 days in average. In multivariable analysis, different factors were associated with the admission: (1) time of the visit (between 19h-21h:

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles